Tianjin Zhihe Biotechnology Co., Ltd. announced that it will issue 10,000,000 equity shares at a price of CNY 1 per share for gross proceeds of CNY 10,000,000 on September 13, 2022. The transaction will include participation from returning investor Anhui Huaheng Biotechnology Co., Ltd. for 25% stake upon completion. After the completion of the transaction, the registered capital of the company will increase from CNY 50,000,000 to CNY 60,000,000.

The transaction has been approved in the eighteenth meeting of the third board of directors of the investor.